Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings? John J. Squiers, MD The Annals of Thoracic Surgery Volume 105, Issue 1, Pages 330-332 (January 2018) DOI: 10.1016/j.athoracsur.2017.02.084 Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Forest plot of the risk ratio of short-term (within 30 days) outcomes after coronary artery bypass grafting (CABG) versus stenting for unprotected left main coronary artery disease. (CI = confidence interval; MAACE = major adverse cardiac and cerebrovascular events; M-H = Mantel-Haenszel test; MI = myocardial infarction; TVR = target vessel revascularization.) The Annals of Thoracic Surgery 2018 105, 330-332DOI: (10.1016/j.athoracsur.2017.02.084) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Forest plot of the risk ratio of long-term (>1 year) outcomes after coronary artery bypass grafting (CABG) versus stenting for unprotected left main coronary artery disease. (CI = confidence interval; MAACE = major adverse cardiac and cerebrovascular events; M-H = Mantel-Haenszel test; MI = myocardial infarction; TVR = target vessel revascularization.) The Annals of Thoracic Surgery 2018 105, 330-332DOI: (10.1016/j.athoracsur.2017.02.084) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions